PHI with Encephalotrigeminal angiomatosis
How does this condition affect your private health insurance?
Encephalotrigeminal angiomatosis, known as Sturge-Weber Syndrome, is a rare, non-hereditary congenital neurocutaneous disorder. It is characterized by a distinctive port-wine stain (facial nevus flammeus), often involving the forehead and upper eyelid. This is typically accompanied by a leptomeningeal angioma (brain angioma) on the same side, leading to neurological complications like seizures, intellectual disability, and hemiparesis. Ocular involvement, especially glaucoma, is also common. The syndrome is progressive, and symptoms may worsen, necessitating lifelong management to control seizures and preserve vision and neurological function.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Lifelong, with symptoms manifesting at birth or in early infancy.
Duration of Illness (Lifetime)
Chronic, lifelong condition requiring continuous medical management.
Cost of Treatment (Initial)
High, including initial diagnostic imaging (MRI, EEG), ophthalmological exams, and management of acute symptoms like seizures or glaucoma.
Cost of Treatment (Lifetime)
Very high, due to ongoing anticonvulsant and antiglaucoma medications, laser therapy for skin lesions, potential surgeries (e.g., epilepsy, glaucoma), and continuous therapeutic interventions (physical, occupational, speech therapy) and regular specialist consultations.
Mortality Rate
Low; however, severe complications such as intractable seizures or status epilepticus can increase risk. With appropriate management, individuals often have a near-normal lifespan.
Risk of Secondary Damages
High, commonly including epilepsy (70-90%), developmental delay (50-60%), intellectual disability (50-60%), glaucoma-induced blindness (30-70%), hemiparesis, stroke-like episodes, and cognitive impairment. Psychological impact from facial disfigurement is also significant.
Probability of Full Recovery
Extremely low; it is a chronic, progressive congenital condition. Treatment focuses on managing symptoms, preventing complications, and improving quality of life, rather than achieving a complete recovery.
Underlying Disease Risk
High probability of associated conditions rather than underlying diseases, including epilepsy (70-90%), glaucoma (30-70%), developmental delay and intellectual disability (50-60%), and contralateral hemiparesis or weakness.